Skip to main content
Top
Published in: Clinical Rheumatology 9/2010

Open Access 01-09-2010 | Original Article

Quality of life and satisfaction with life in SLE patients—the importance of clinical manifestations

Authors: Lilianna Kulczycka, Anna Sysa-Jędrzejowska, Ewa Robak

Published in: Clinical Rheumatology | Issue 9/2010

Login to get access

Abstract

To assess the correlation between quality of life (QoL) and satisfaction with life (SL) in SLE patients and correlate both with clinical symptoms of the disease. The study was performed in 83 patients. QoL was assessed by Short Form 36, and SL was assessed by the Satisfaction with Life Scale. Clinical manifestations presented at the time of examination were taken into consideration. SLE patients assessed their QoL and SL as rather low. Those with photosensitivity as well as neurological symptoms presented lower QoL in particular domains, while those with renal manifestation of SLE assessed their QoL as higher. Similar observations were made for SL only in relation to neurological symptoms. Moreover, our findings show that although SL is a part of QoL, both these parameters should be distinguished in order to fully assess the state of the patient.
Literature
1.
go back to reference Felce D, Perry J (1995) Quality of life: it’s definition and measurement. Res Dev Disabil 16:51–74CrossRefPubMed Felce D, Perry J (1995) Quality of life: it’s definition and measurement. Res Dev Disabil 16:51–74CrossRefPubMed
2.
go back to reference Dziurowicz-Kozłowska A (2002) Wokół pojęcia jakości życia. Psychologia Jakości Życia 1:77–99 Dziurowicz-Kozłowska A (2002) Wokół pojęcia jakości życia. Psychologia Jakości Życia 1:77–99
3.
go back to reference Schipper H (1990) Quality of life: principles of the clinical paradigm. J Psychol Oncol 8:171–185CrossRef Schipper H (1990) Quality of life: principles of the clinical paradigm. J Psychol Oncol 8:171–185CrossRef
4.
go back to reference Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Int Med 118:622–629PubMed Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Int Med 118:622–629PubMed
5.
go back to reference Muldoon MF, Barger SD, Manuck SB (1998) What are quality of life measurements measuring? BMJ 316:542–545PubMed Muldoon MF, Barger SD, Manuck SB (1998) What are quality of life measurements measuring? BMJ 316:542–545PubMed
7.
go back to reference Bowling A (1997) Measuring health. Open University Press Buckingham, Philadelphia Bowling A (1997) Measuring health. Open University Press Buckingham, Philadelphia
8.
9.
go back to reference Gladman DD (1995) Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 7:402–408CrossRefPubMed Gladman DD (1995) Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 7:402–408CrossRefPubMed
10.
go back to reference Liang MH, Socher SA, Larson MG et al (1989) Reliability and validity of six system for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheumatol 7:817–823 Liang MH, Socher SA, Larson MG et al (1989) Reliability and validity of six system for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheumatol 7:817–823
11.
go back to reference Abrahamowicz M, Fortin PR, Du BR et al (1998) The relationship between disease activity and expert physician’s decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials. J Rheumatol 25:277–284PubMed Abrahamowicz M, Fortin PR, Du BR et al (1998) The relationship between disease activity and expert physician’s decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials. J Rheumatol 25:277–284PubMed
12.
go back to reference Griffiths B, Mosca M, Gordon C (2005) Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity index. Best Pract Res Clin Rheumatol 19:685–708CrossRefPubMed Griffiths B, Mosca M, Gordon C (2005) Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity index. Best Pract Res Clin Rheumatol 19:685–708CrossRefPubMed
13.
go back to reference Ware JE, Kosinski M, Dewey JE (2000) How to score version 2 of the SF-36® Health Survey. QualityMetric Incorporated, Lincoln, RI Ware JE, Kosinski M, Dewey JE (2000) How to score version 2 of the SF-36® Health Survey. QualityMetric Incorporated, Lincoln, RI
14.
go back to reference Juczyński Z (2001) Narzędzia pomiaru w promocji i psychologii zdrowia, Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego, Warszawa Juczyński Z (2001) Narzędzia pomiaru w promocji i psychologii zdrowia, Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego, Warszawa
15.
go back to reference Stoll T, Gordon C, Seifert B et al (1997) Consistency and validity of patient administrated assessment of quality of life by MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 24:1608–1614PubMed Stoll T, Gordon C, Seifert B et al (1997) Consistency and validity of patient administrated assessment of quality of life by MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 24:1608–1614PubMed
16.
go back to reference Gladman DD, Urowitz MB, Gough J et al (1997) Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 24:2145–2148PubMed Gladman DD, Urowitz MB, Gough J et al (1997) Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 24:2145–2148PubMed
17.
go back to reference Stoll T (2001) Prediction of depression in systemic lupus erythematosus patients using SF-26 Mental Health Scores. Rheumatology 40:695–698CrossRefPubMed Stoll T (2001) Prediction of depression in systemic lupus erythematosus patients using SF-26 Mental Health Scores. Rheumatology 40:695–698CrossRefPubMed
18.
go back to reference Benitha R, Tikly M (2007) Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 26:24–29CrossRefPubMed Benitha R, Tikly M (2007) Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 26:24–29CrossRefPubMed
19.
go back to reference Freire EA, Maia IO, Nepomuceno JC et al (2007) Damage index assessment and quality of life in systemic lupus erythematosus patients (with long term disease) in Northeastern Brazil. Clin Rheumatol 26:423–428CrossRefPubMed Freire EA, Maia IO, Nepomuceno JC et al (2007) Damage index assessment and quality of life in systemic lupus erythematosus patients (with long term disease) in Northeastern Brazil. Clin Rheumatol 26:423–428CrossRefPubMed
20.
go back to reference Rinaldi S, Doria A, Salaffi F et al (2004) Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatol 43:1574–1579CrossRef Rinaldi S, Doria A, Salaffi F et al (2004) Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatol 43:1574–1579CrossRef
21.
go back to reference Alarcon GS, McGwin G, Uribe A et al (2004) Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in disease course. Arthritis Rheumatol 51:465–474CrossRef Alarcon GS, McGwin G, Uribe A et al (2004) Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in disease course. Arthritis Rheumatol 51:465–474CrossRef
22.
go back to reference Kulczycka L, Sysa-Jędrzejowska A, Zalewska-Janowska A et al (2008) Quality of life and socioeconomic factors in Polish patients with systemic lupus erythematosus. JEADV 22:1218–1226PubMed Kulczycka L, Sysa-Jędrzejowska A, Zalewska-Janowska A et al (2008) Quality of life and socioeconomic factors in Polish patients with systemic lupus erythematosus. JEADV 22:1218–1226PubMed
23.
go back to reference Saba J, Quinet RJ, Davis WE et al (2003) Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in systemic lupus erythematosus (m-SLAM). Jt Bone Spine 70:348–351CrossRef Saba J, Quinet RJ, Davis WE et al (2003) Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in systemic lupus erythematosus (m-SLAM). Jt Bone Spine 70:348–351CrossRef
24.
go back to reference Vu TV, Escalante A (1999) A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease. J Rheumatol 26:2595–2601PubMed Vu TV, Escalante A (1999) A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease. J Rheumatol 26:2595–2601PubMed
25.
go back to reference Gladman DD, Urowitz MB, Ong A et al (1996) Lack of correlation among 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 14:305–308PubMed Gladman DD, Urowitz MB, Ong A et al (1996) Lack of correlation among 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 14:305–308PubMed
26.
go back to reference Dobkin P, da Costa D, Drista M et al (1999) Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res 12:401–410CrossRefPubMed Dobkin P, da Costa D, Drista M et al (1999) Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res 12:401–410CrossRefPubMed
27.
go back to reference Gilboe IM, Kvien TK, Husby G (2001) Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years. J Rheumatol 28:266–274PubMed Gilboe IM, Kvien TK, Husby G (2001) Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years. J Rheumatol 28:266–274PubMed
28.
go back to reference Doria A, Rinaldi S, Ermani M et al (2004) Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatol 43:1580–1586CrossRef Doria A, Rinaldi S, Ermani M et al (2004) Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatol 43:1580–1586CrossRef
29.
go back to reference Wang C, Mayo NE, Fortin PR (2001) The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 28:525–532PubMed Wang C, Mayo NE, Fortin PR (2001) The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 28:525–532PubMed
30.
go back to reference Sutcliffe N, Clarke AE, Levinton C et al (1999) Associates of health status in patients with systemic lupus erythematosus. J Rheumatol 26:2352–2356PubMed Sutcliffe N, Clarke AE, Levinton C et al (1999) Associates of health status in patients with systemic lupus erythematosus. J Rheumatol 26:2352–2356PubMed
31.
go back to reference Thumboo J, Fong KY, Chan SP et al (2000) A prospective study of factors affecting quality of life I systemic lupus erythematosus. J Rheumatol 27:1414–1420PubMed Thumboo J, Fong KY, Chan SP et al (2000) A prospective study of factors affecting quality of life I systemic lupus erythematosus. J Rheumatol 27:1414–1420PubMed
32.
go back to reference Thumboo J, Fong KY, Ng TP et al (1999) Validation of the MOS SF-36 for quality of life of patients with systemic lupus erythematosus in Singapore. J Rheumatol 26:96–102 Thumboo J, Fong KY, Ng TP et al (1999) Validation of the MOS SF-36 for quality of life of patients with systemic lupus erythematosus in Singapore. J Rheumatol 26:96–102
Metadata
Title
Quality of life and satisfaction with life in SLE patients—the importance of clinical manifestations
Authors
Lilianna Kulczycka
Anna Sysa-Jędrzejowska
Ewa Robak
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1509-0

Other articles of this Issue 9/2010

Clinical Rheumatology 9/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.